Published in Nat Rev Gastroenterol Hepatol on April 01, 2016
Ion channelopathies in functional GI disorders. Am J Physiol Gastrointest Liver Physiol (2016) 0.84
An Orally Active Cannabis Extract with High Content in Cannabidiol attenuates Chemically-induced Intestinal Inflammation and Hypermotility in the Mouse. Front Pharmacol (2016) 0.77
Efficacy of Synbiotics in Patients with Slow Transit Constipation: A Prospective Randomized Trial. Nutrients (2016) 0.75
Peripherally acting μ-opioid receptor antagonists as treatment options for constipation in noncancer pain patients on chronic opioid therapy. Patient Prefer Adherence (2017) 0.75
Antibiotics-induced depletion of mice microbiota induces changes in host serotonin biosynthesis and intestinal motility. J Transl Med (2017) 0.75
Efficacy and Predictors for Biofeedback Therapeutic Outcome in Patients with Dyssynergic Defecation. Gastroenterol Res Pract (2017) 0.75
Targeting Small Bowel Receptors to Treat Constipation and Diarrhea. Curr Gastroenterol Rep (2017) 0.75
Balloon Expulsion Test Does Not Seem to Be Useful for Screening or Exclusion of Dyssynergic Defecation as a Single Test. J Neurogastroenterol Motil (2017) 0.75
Prolonged-Release Oxycodone/Naloxone Improves Anal Sphincter Relaxation Compared to Oxycodone Plus Macrogol 3350. Dig Dis Sci (2017) 0.75
The functional gastrointestinal disorders and the Rome III process. Gastroenterology (2006) 8.71
A diet low in FODMAPs reduces symptoms of irritable bowel syndrome. Gastroenterology (2013) 8.37
Epidemiology of constipation in North America: a systematic review. Am J Gastroenterol (2004) 4.89
Randomised clinical trial: dried plums (prunes) vs. psyllium for constipation. Aliment Pharmacol Ther (2011) 3.63
American Gastroenterological Association technical review on constipation. Gastroenterology (2013) 3.27
Randomized controlled trial of biofeedback, sham feedback, and standard therapy for dyssynergic defecation. Clin Gastroenterol Hepatol (2007) 3.16
Efficacy and safety of traditional medical therapies for chronic constipation: systematic review. Am J Gastroenterol (2005) 3.10
Biofeedback is superior to laxatives for normal transit constipation due to pelvic floor dyssynergia. Gastroenterology (2006) 2.98
Linaclotide for irritable bowel syndrome with constipation: a 26-week, randomized, double-blind, placebo-controlled trial to evaluate efficacy and safety. Am J Gastroenterol (2012) 2.90
Functional anorectal disorders. Gastroenterology (2006) 2.80
Linaclotide inhibits colonic nociceptors and relieves abdominal pain via guanylate cyclase-C and extracellular cyclic guanosine 3',5'-monophosphate. Gastroenterology (2013) 2.56
Lactulose versus Polyethylene Glycol for Chronic Constipation. Cochrane Database Syst Rev (2010) 2.52
Obstructive defecation: a failure of rectoanal coordination. Am J Gastroenterol (1998) 2.31
An epidemiological survey of constipation in canada: definitions, rates, demographics, and predictors of health care seeking. Am J Gastroenterol (2001) 2.30
Irritable bowel syndrome: a clinical review. JAMA (2015) 2.26
American Neurogastroenterology and Motility Society consensus statement on intraluminal measurement of gastrointestinal and colonic motility in clinical practice. Neurogastroenterol Motil (2008) 2.16
The health-related quality of life and economic burden of constipation. Pharmacoeconomics (2005) 2.14
A 12-week, randomized, controlled trial with a 4-week randomized withdrawal period to evaluate the efficacy and safety of linaclotide in irritable bowel syndrome with constipation. Am J Gastroenterol (2012) 2.11
Naloxegol for opioid-induced constipation in patients with noncancer pain. N Engl J Med (2014) 2.05
Effect of a selective chloride channel activator, lubiprostone, on gastrointestinal transit, gastric sensory, and motor functions in healthy volunteers. Am J Physiol Gastrointest Liver Physiol (2006) 1.94
Evaluation and surgical treatment of severe chronic constipation. Ann Surg (1991) 1.92
Systematic review on the management of chronic constipation in North America. Am J Gastroenterol (2005) 1.85
Sacral nerve stimulation for intractable constipation. Gut (2010) 1.82
Systematic review: impact of constipation on quality of life in adults and children. Aliment Pharmacol Ther (2010) 1.80
Systematic review: dietary fibre and FODMAP-restricted diet in the management of constipation and irritable bowel syndrome. Aliment Pharmacol Ther (2015) 1.78
Epidemiology of constipation in children and adults: a systematic review. Best Pract Res Clin Gastroenterol (2011) 1.77
Linaclotide, through activation of guanylate cyclase C, acts locally in the gastrointestinal tract to elicit enhanced intestinal secretion and transit. Eur J Pharmacol (2010) 1.74
Evaluation of gastrointestinal transit in clinical practice: position paper of the American and European Neurogastroenterology and Motility Societies. Neurogastroenterol Motil (2011) 1.72
The brain-gut axis in abdominal pain syndromes. Annu Rev Med (2011) 1.68
Meta-analysis: Alvimopan vs. placebo in the treatment of post-operative ileus. Aliment Pharmacol Ther (2006) 1.66
Effect of laxatives and pharmacological therapies in chronic idiopathic constipation: systematic review and meta-analysis. Gut (2011) 1.62
Dynamic MR imaging of the pelvic floor performed with patient sitting in an open-magnet unit versus with patient supine in a closed-magnet unit. Radiology (2002) 1.60
Dyssynergic defecation and biofeedback therapy. Gastroenterol Clin North Am (2008) 1.59
Results of 24-h manometric recording of colonic motor activity with endoluminal instillation of bisacodyl in patients with severe chronic slow transit constipation. Neurogastroenterol Motil (2004) 1.59
Influence of body position and stool characteristics on defecation in humans. Am J Gastroenterol (2006) 1.58
Oral bisacodyl is effective and well-tolerated in patients with chronic constipation. Clin Gastroenterol Hepatol (2011) 1.58
Dyssynergic defecation: demographics, symptoms, stool patterns, and quality of life. J Clin Gastroenterol (2004) 1.58
Results of colectomy for severe idiopathic constipation in women (Arbuthnot Lane's disease). Br J Surg (1984) 1.58
Overlap of gastrointestinal symptom complexes in a US community. Neurogastroenterol Motil (2005) 1.56
Outcome of colectomy for slow transit constipation. Ann Surg (1999) 1.47
Digital rectal examination is a useful tool for identifying patients with dyssynergia. Clin Gastroenterol Hepatol (2010) 1.43
Systematic review: the role of different types of fibre in the treatment of irritable bowel syndrome. Aliment Pharmacol Ther (2004) 1.41
Treatment of anismus in intractable constipation with botulinum A toxin. Lancet (1988) 1.39
Clinical utility of diagnostic tests for constipation in adults: a systematic review. Am J Gastroenterol (2005) 1.32
Wireless pH-motility capsule for colonic transit: prospective comparison with radiopaque markers in chronic constipation. Neurogastroenterol Motil (2010) 1.29
Ambulatory 24-hour colonic manometry in slow-transit constipation. Am J Gastroenterol (2004) 1.26
Short-chain carbohydrates and functional gastrointestinal disorders. Am J Gastroenterol (2013) 1.23
Psychological profiles and quality of life differ between patients with dyssynergia and those with slow transit constipation. J Psychosom Res (2007) 1.22
Association between physical activity, fiber intake, and other lifestyle variables and constipation in a study of women. Am J Gastroenterol (2003) 1.21
Systematic review: the effects of fibre in the management of chronic idiopathic constipation. Aliment Pharmacol Ther (2011) 1.20
Phenotypic variation of colonic motor functions in chronic constipation. Gastroenterology (2009) 1.20
Emerging treatments in neurogastroenterology: a multidisciplinary working group consensus statement on opioid-induced constipation. Neurogastroenterol Motil (2014) 1.19
Review article: The role of serotonergic agents in the treatment of patients with primary chronic constipation. Aliment Pharmacol Ther (2005) 1.17
Constipation: evaluation and treatment of colonic and anorectal motility disorders. Gastroenterol Clin North Am (2007) 1.14
Colonic transit time and IBS symptoms: what's the link? Am J Gastroenterol (2012) 1.14
Pathophysiology and role of biofeedback therapy in solitary rectal ulcer syndrome. Am J Gastroenterol (2006) 1.14
Dyssynergic defecation. Gastroenterol Clin North Am (2001) 1.13
Colectomy for constipation: physiologic investigation is the key to success. Dis Colon Rectum (1991) 1.11
Tolerability, gut effects, and pharmacokinetics of methylnaltrexone following repeated intravenous administration in humans. J Clin Pharmacol (2005) 1.10
Physiological tests to predict long-term outcome of total abdominal colectomy for intractable constipation. Am J Gastroenterol (1995) 1.09
Gastrointestinal neuromuscular pathology in chronic constipation. Best Pract Res Clin Gastroenterol (2011) 1.08
An Update on Post-infectious Irritable Bowel Syndrome: Role of Genetics, Immune Activation, Serotonin and Altered Microbiome. J Neurogastroenterol Motil (2012) 1.07
Outcome of segmental colonic resection for slow-transit constipation. Br J Surg (2002) 1.07
Long-term safety and effectiveness of lubiprostone, a chloride channel (ClC-2) activator, in patients with chronic idiopathic constipation. Dig Dis Sci (2011) 1.06
American Gastroenterological Association Institute Technical Review on the pharmacological management of irritable bowel syndrome. Gastroenterology (2014) 1.05
Pancolonic spatiotemporal mapping reveals regional deficiencies in, and disorganization of colonic propagating pressure waves in severe constipation. Neurogastroenterol Motil (2010) 1.05
Ileorectal anastomosis for slow transit constipation: long-term functional and quality of life results. J Gastrointest Surg (2006) 1.04
Validation of the balloon evacuation test: reproducibility and agreement with findings from anorectal manometry and electromyography. Clin Gastroenterol Hepatol (2014) 1.00
Biofeedback therapy for constipation in adults. Best Pract Res Clin Gastroenterol (2011) 1.00
Association of low dietary intake of fiber and liquids with constipation: evidence from the National Health and Nutrition Examination Survey. Am J Gastroenterol (2013) 1.00
Methylnaltrexone. Drugs (2010) 0.99
Functional chest pain: esophageal or overlapping functional disorder. J Clin Gastroenterol (2007) 0.99
Normal aspects of colorectal motility and abnormalities in slow transit constipation. World J Gastroenterol (2005) 0.98
Systematic review with meta-analysis: highly selective 5-HT4 agonists (prucalopride, velusetrag or naronapride) in chronic constipation. Aliment Pharmacol Ther (2013) 0.98
Functional morphology of anal sphincter complex unveiled by high definition anal manometery and three dimensional ultrasound imaging. Neurogastroenterol Motil (2011) 0.96
Prospective, randomized trial comparing four biofeedback techniques for patients with constipation. Dis Colon Rectum (1999) 0.95
Colonic motility in man: features in normal subjects and in patients with chronic idiopathic constipation. Am J Gastroenterol (1999) 0.95
Brain and gut interactions in irritable bowel syndrome: new paradigms and new understandings. Curr Gastroenterol Rep (2014) 0.94
Altered periodic rectal motor activity: a mechanism for slow transit constipation. Neurogastroenterol Motil (2001) 0.92
Guanylate cyclase C agonists: emerging gastrointestinal therapies and actions. Gastroenterology (2015) 0.90
Pharmacologic management of chronic constipation. Gastroenterol Clin North Am (2010) 0.89
Treatment efficacy of sacral nerve stimulation in slow transit constipation: a two-phase, double-blind randomized controlled crossover study. Am J Gastroenterol (2015) 0.89
Clinical utility of colonic manometry in slow transit constipation. Neurogastroenterol Motil (2013) 0.87
Advances in pharmacotherapy for opioid-induced constipation - a systematic review. Expert Opin Pharmacother (2014) 0.86
Percutaneous colonoscopic cecostomy for management of chronic constipation in children. Gastrointest Endosc (2001) 0.86
High resolution and high definition anorectal manometry and pressure topography: diagnostic advance or a new kid on the block? Curr Gastroenterol Rep (2013) 0.86
Colonic dysmotility in constipation. Best Pract Res Clin Gastroenterol (2011) 0.86
Diagnostic testing in patients with chronic constipation. Curr Gastroenterol Rep (2006) 0.86
Rectal sensorimotor dysfunction in constipation. Best Pract Res Clin Gastroenterol (2011) 0.85
MR defecography in patients with dyssynergic defecation: spectrum of imaging findings and diagnostic value. Br J Radiol (2011) 0.84
Management of obstructed defecation. World J Gastroenterol (2015) 0.84
Diagnostic testing for dyssynergic defecation in chronic constipation: meta-analysis. Neurogastroenterol Motil (2013) 0.83
Long-term results of the antegrade continent enema procedure for constipation in adults. Colorectal Dis (2004) 0.83
ANMS-ESNM position paper and consensus guidelines on biofeedback therapy for anorectal disorders. Neurogastroenterol Motil (2015) 0.82
Prucalopride: evaluation of the pharmacokinetics, pharmacodynamics, efficacy and safety in the treatment of chronic constipation. Expert Opin Drug Metab Toxicol (2012) 0.81
Long-term efficacy of biofeedback therapy in patients with dyssynergic defecation: results of a median 44 months follow-up. Neurogastroenterol Motil (2015) 0.81
Open-magnet MR defaecography compared with evacuation proctography in the diagnosis and management of patients with rectal intussusception. Colorectal Dis (2004) 0.81
Sacral nerve stimulation for faecal incontinence and constipation in adults. Cochrane Database Syst Rev (2015) 0.81
Assessment of rectal afferent neuronal function and brain activity in patients with constipation and rectal hyposensitivity. Neurogastroenterol Motil (2012) 0.79
Antibiotics for irritable bowel syndrome: rationale and current evidence. Curr Gastroenterol Rep (2012) 0.79